EATG » Hepatitis

Hepatitis

Scientists discover how Hepatitis C ‘ghosts’ our immune system

Scientists from Trinity College Dublin have discovered how the highly infectious and sometimes deadly Hepatitis C virus (HCV) “ghosts” our immune system and remains undiagnosed in many people. They report their…

HIV-related factors predict reinforced hepatitis B vaccination success

Certain characteristics and HIV-related factors may help predict whether certain demographics of people with HIV will have an optimal response to reinforced hepatitis B virus vaccination, according to an article…

Trial evaluating experimental hepatitis C vaccine concludes

An experimental vaccine was not found to be effective at preventing chronic hepatitis C virus (HCV) infection in adults, according to results from a clinical trial sponsored by the National…

HCV Infection May Be a Modifiable Cardiovascular Risk Factor

For the estimated 71 million people worldwide who live with chronic hepatitis C virus (HCV) infection, the risk for cirrhosis and liver cancer is well established. These individuals often experience…

Common polymorphism responsible for HCV genotype 3 resistance to Sovaldi

Researchers identified a common polymorphism and a rare variant combination in hepatitis C genotype 3 that are responsible for a reduced response to Sovaldi, according to a study published in Gastroenterology.…

A record linkage study on the causes of death in people with HCV in England

Data linkage between laboratory diagnosis and death data is an important tool for monitoring all-cause mortality in patients with hepatitis C virus (HCV) and quantifying under-reporting of HCV on death…

Cocrystal Pharma commences patient enrollment for Hong Kong Phase 2a study of CC-31244 for ultra-short treatment of hepatitis C

- Humanity & Health Research Centre conducting differentiated Phase 2a study evaluating CC-31244 for the ultra-short treatment of hepatitis C (HepC) - Asia market represents one of the largest HepC…

Tenofovir disoproxil fumarate for nucleos(t)ide analog-resistant chronic HBV

In patients with chronic hepatitis B (CHB) that is resistant to multiple nucleos(t)ide analogs (NUCs), long-term tenofovir disoproxil fumarate (TDF) monotherapy provided a virologic response in most, but it was…

What do people who inject drugs think of point-of-care HCV testing?

Point-of-care testing to diagnose HCV infection has the potential to eliminate the need for multiple appointments to confirm chronic infection. An oral antibody test can provide a result in 20…

Widespread testing, treatment of hepatitis C in US prisons improves outcomes

BOSTON -- At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with…

1 4 5 6 7 8 115